Enoyl-(Acyl-Carrier-Protein) Reductase (NADH)
Acyl Carrier Protein
Enoyl-(Acyl-Carrier Protein) Reductase (NADPH, B-Specific)
Fatty Acid Synthases
Fatty Acid Synthase, Type II
Molecular Sequence Data
Acyl-Carrier Protein S-Malonyltransferase
Transferases (Other Substituted Phosphate Groups)
Amino Acid Sequence
Malonyl Coenzyme A
Sequence Homology, Amino Acid
Acyl Coenzyme A
Hydroxymethylglutaryl CoA Reductases
Triclosan is an antimicrobial agent that is commonly used in personal care products such as soaps, toothpaste, and deodorants. It is also used in some industrial and agricultural applications. In the medical field, triclosan is sometimes used as an antiseptic to help prevent the spread of infection. However, there is some concern about the potential health effects of triclosan, and its use in personal care products is being reevaluated by regulatory agencies in some countries.
Acyl Carrier Protein (ACP) is a small, soluble protein that plays a crucial role in fatty acid biosynthesis. It is a carrier molecule that shuttles acyl groups (long-chain fatty acids) between enzymes involved in the biosynthesis pathway. In the process of fatty acid synthesis, ACP binds to an acyl group, which is then transferred to another enzyme in the pathway. This process is repeated several times until the desired length of fatty acid chain is synthesized. ACP is found in all living organisms and is essential for the production of fatty acids, which are important components of cell membranes, signaling molecules, and energy storage molecules. In the medical field, ACP is often studied in the context of metabolic disorders such as fatty acid oxidation disorders, where there are defects in the enzymes involved in fatty acid metabolism.
Pantetheine is a compound that is naturally found in many foods, including meat, poultry, fish, and eggs. It is also available as a dietary supplement. In the medical field, pantetheine is used to treat a variety of conditions, including liver disease, heart disease, and high blood pressure. It is also used to improve the function of the immune system and to help prevent the development of certain types of cancer. Pantetheine is thought to work by increasing the production of certain enzymes in the body, which can help to improve the function of the liver and other organs. It is important to note that more research is needed to fully understand the effects of pantetheine on the human body and to determine the optimal dosage for different conditions.
Oxidoreductases are a class of enzymes that catalyze redox reactions, which involve the transfer of electrons from one molecule to another. These enzymes play a crucial role in many biological processes, including metabolism, energy production, and detoxification. In the medical field, oxidoreductases are often studied in relation to various diseases and conditions. For example, some oxidoreductases are involved in the metabolism of drugs and toxins, and changes in their activity can affect the efficacy and toxicity of these substances. Other oxidoreductases are involved in the production of reactive oxygen species (ROS), which can cause cellular damage and contribute to the development of diseases such as cancer and aging. Oxidoreductases are also important in the diagnosis and treatment of certain diseases. For example, some oxidoreductases are used as markers of liver disease, and changes in their activity can indicate the severity of the disease. In addition, some oxidoreductases are targets for drugs used to treat diseases such as cancer and diabetes. Overall, oxidoreductases are a diverse and important class of enzymes that play a central role in many biological processes and are the subject of ongoing research in the medical field.
Fatty acid synthases (FAS) are a group of enzymes that are responsible for the de novo synthesis of long-chain fatty acids in the body. These enzymes are found in the cytoplasm of most cells and are composed of multiple subunits that work together to catalyze a series of reactions that convert acetyl-CoA and malonyl-CoA into palmitate, a 16-carbon fatty acid. Fatty acid synthases play a critical role in the metabolism of lipids, which are essential for the production of energy, the formation of cell membranes, and the synthesis of other important molecules such as hormones and signaling molecules. Dysregulation of fatty acid synthases has been implicated in a number of diseases, including obesity, diabetes, and certain types of cancer. In the medical field, fatty acid synthases are often studied as potential targets for the development of new drugs and therapies for these and other diseases. For example, drugs that inhibit fatty acid synthases have been shown to have anti-cancer effects in preclinical studies, and are currently being tested in clinical trials for their potential to treat various types of cancer.
Alcohol oxidoreductases are a group of enzymes that catalyze the oxidation of alcohols. In the medical field, these enzymes are of particular interest because they play a key role in the metabolism of alcohol in the body. There are several different types of alcohol oxidoreductases, including alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). ADH is responsible for converting alcohol (ethanol) into acetaldehyde, a toxic substance that can cause a range of symptoms when present in high concentrations, including headache, nausea, and dizziness. ALDH is responsible for converting acetaldehyde into acetate, a non-toxic substance that can be further metabolized by the body. Alcohol oxidoreductases are found in a variety of tissues throughout the body, including the liver, brain, and lungs. In the liver, ADH and ALDH are particularly important for metabolizing alcohol, as this organ is responsible for processing a large amount of the alcohol that is consumed. Disruptions in the activity of alcohol oxidoreductases can lead to a range of health problems, including alcohol dependence, liver disease, and certain types of cancer. For example, individuals who are unable to effectively metabolize alcohol due to a deficiency in ADH or ALDH may be more susceptible to the negative effects of alcohol consumption, such as liver damage and addiction.
Fatty acids are organic compounds that are composed of a long chain of carbon atoms with hydrogen atoms attached to them. They are a type of lipid, which are molecules that are insoluble in water but soluble in organic solvents. Fatty acids are an important source of energy for the body and are also used to synthesize other important molecules, such as hormones and cell membranes. In the medical field, fatty acids are often studied in relation to their role in various diseases, such as cardiovascular disease, diabetes, and obesity. They are also used in the development of new drugs and therapies.
Fatty Acid Synthase, Type II (FASN) is an enzyme that plays a crucial role in the biosynthesis of long-chain fatty acids in the human body. It is a large, multifunctional enzyme that is responsible for catalyzing the de novo synthesis of fatty acids from acetyl-CoA and malonyl-CoA. FASN is primarily located in the endoplasmic reticulum of liver and adipose tissue cells, but it is also present in other tissues such as the heart, skeletal muscle, and brain. The enzyme is composed of multiple domains, including an acetyltransferase domain, a malonyltransferase domain, and a thioesterase domain. FASN is involved in the production of various types of fatty acids, including palmitate, stearate, and oleate, which are essential components of cell membranes and signaling molecules. It also plays a role in the synthesis of triglycerides, cholesterol esters, and phospholipids, which are important for energy storage and cell signaling. Abnormal regulation of FASN activity has been linked to various diseases, including obesity, diabetes, and cancer. For example, increased FASN expression has been observed in many types of cancer, and it has been proposed as a potential therapeutic target for cancer treatment.
Bacterial proteins are proteins that are synthesized by bacteria. They are essential for the survival and function of bacteria, and play a variety of roles in bacterial metabolism, growth, and pathogenicity. Bacterial proteins can be classified into several categories based on their function, including structural proteins, metabolic enzymes, regulatory proteins, and toxins. Structural proteins provide support and shape to the bacterial cell, while metabolic enzymes are involved in the breakdown of nutrients and the synthesis of new molecules. Regulatory proteins control the expression of other genes, and toxins can cause damage to host cells and tissues. Bacterial proteins are of interest in the medical field because they can be used as targets for the development of antibiotics and other antimicrobial agents. They can also be used as diagnostic markers for bacterial infections, and as vaccines to prevent bacterial diseases. Additionally, some bacterial proteins have been shown to have therapeutic potential, such as enzymes that can break down harmful substances in the body or proteins that can stimulate the immune system.
Crystallography, X-ray is a technique used in the medical field to study the structure of biological molecules, such as proteins and nucleic acids, by analyzing the diffraction patterns produced by X-rays passing through the sample. This technique is used to determine the three-dimensional structure of these molecules, which is important for understanding their function and for developing new drugs and therapies. X-ray crystallography is a powerful tool that has been instrumental in advancing our understanding of many important biological processes and diseases.
Polyketide Synthases (PKSs) are a class of enzymes that are involved in the biosynthesis of a wide range of natural products, including antibiotics, immunosuppressants, and anticancer drugs. These enzymes are responsible for the assembly of long-chain polyketides, which are complex organic molecules composed of multiple units of acetyl-CoA. In the medical field, PKSs are of particular interest due to their ability to produce a diverse array of bioactive compounds with therapeutic potential. For example, the antibiotic erythromycin is synthesized by a type of PKS called a type I PKS, while the immunosuppressant cyclosporine is produced by a type II PKS. Researchers are actively exploring the potential of PKSs as a source of new drugs and drug candidates, as well as as a means of producing biofuels and other valuable chemicals.
Acyl-carrier protein S-malonyltransferase (ACPSMT) is an enzyme that plays a crucial role in the biosynthesis of fatty acids. It catalyzes the transfer of a malonyl group from malonyl-CoA to acyl-carrier protein (ACP), which is a carrier molecule that shuttles fatty acid intermediates between different enzymes involved in fatty acid biosynthesis. The reaction catalyzed by ACPSMT is the first committed step in the biosynthesis of long-chain fatty acids, and it is essential for the production of all fatty acids with more than four carbon atoms. The enzyme is found in bacteria, plants, and animals, and its activity is regulated by various factors, including the availability of substrates and the presence of inhibitors. In the medical field, ACPSMT is of interest because it is involved in the biosynthesis of fatty acids, which are important components of cell membranes and play a role in energy metabolism. Mutations in the gene encoding ACPSMT have been associated with certain genetic disorders, such as acyl-CoA dehydrogenase deficiency, which can lead to problems with energy metabolism and the breakdown of fatty acids. Additionally, ACPSMT has been targeted as a potential therapeutic target for the treatment of obesity and other metabolic disorders.
Acyltransferases are a class of enzymes that catalyze the transfer of an acyl group from one molecule to another. In the medical field, acyltransferases play important roles in various metabolic pathways, including fatty acid metabolism, cholesterol metabolism, and drug metabolism. One example of an acyltransferase enzyme is acetyl-CoA carboxylase, which is involved in the synthesis of fatty acids. This enzyme catalyzes the transfer of a carboxyl group from bicarbonate to acetyl-CoA, producing malonyl-CoA. Malonyl-CoA is then used as a substrate for fatty acid synthesis. Another example of an acyltransferase enzyme is the cholesterol biosynthesis enzyme HMG-CoA reductase. This enzyme catalyzes the transfer of a hydrogen atom from NADPH to HMG-CoA, producing mevalonate. Mevalonate is then used as a substrate for the synthesis of cholesterol. In the field of drug metabolism, acyltransferases are involved in the metabolism of many drugs. For example, the cytochrome P450 enzyme CYP2C9 is an acyltransferase that is involved in the metabolism of several drugs, including warfarin and diazepam. Overall, acyltransferases play important roles in various metabolic pathways and are important targets for the development of new drugs and therapies.
Antitubercular agents, also known as antitubercular drugs or TB drugs, are medications used to treat tuberculosis (TB), a bacterial infection caused by Mycobacterium tuberculosis. These drugs work by inhibiting the growth and reproduction of the bacteria, thereby reducing the severity and duration of the infection. There are several classes of antitubercular agents, including: 1. Isoniazid (INH) 2. Rifampin (RIF) 3. Ethambutol (EMB) 4. Pyrazinamide (PZA) 5. Streptomycin (SM) 6. Fluoroquinolones (FQs) 7. Bedaquiline 8. Delamanid These drugs are typically used in combination to increase their effectiveness and reduce the risk of drug resistance. The duration of treatment depends on the type and severity of the infection, but it can range from several months to a year or more. It is important to note that antitubercular agents can have side effects, and patients should be closely monitored during treatment to ensure that the benefits outweigh the risks. Additionally, proper infection control measures should be taken to prevent the spread of TB in healthcare settings and the community.
NAD stands for nicotinamide adenine dinucleotide, which is a coenzyme found in all living cells. It plays a crucial role in various metabolic processes, including energy production, DNA repair, and regulation of gene expression. In the medical field, NAD is often used as a supplement to support cellular health and improve overall well-being. It is also being studied for its potential therapeutic applications in treating conditions such as depression, anxiety, and chronic pain.
Coenzyme A (CoA) is a small molecule that plays a crucial role in many metabolic pathways in the body. It is a thiol group (a sulfur-containing molecule) attached to a fatty acid molecule, and it serves as a carrier molecule for fatty acids in the body. In the medical field, CoA is involved in a variety of processes, including the breakdown of carbohydrates, fats, and proteins, as well as the synthesis of lipids and cholesterol. It is also involved in the metabolism of certain drugs and toxins. Disruptions in CoA metabolism can lead to a variety of medical conditions, including fatty acid oxidation disorders, which are a group of rare genetic disorders that affect the body's ability to break down fatty acids for energy. These disorders can cause a range of symptoms, including muscle weakness, developmental delays, and neurological problems. In addition, CoA is also involved in the metabolism of certain vitamins and minerals, such as vitamin B12 and selenium, and deficiencies in these nutrients can also affect CoA metabolism and lead to health problems.
Pantothenic acid is a water-soluble vitamin that is essential for human health. It is also known as vitamin B5 and is a member of the B-complex vitamins. Pantothenic acid plays a crucial role in the metabolism of carbohydrates, proteins, and fats, and is involved in the production of energy in the body. It is also important for the synthesis of hormones, cholesterol, and neurotransmitters. Deficiency of pantothenic acid can lead to symptoms such as fatigue, muscle pain, and numbness or tingling in the hands and feet. Pantothenic acid is found in a variety of foods, including meats, poultry, fish, eggs, dairy products, whole grains, and vegetables. It is also available as a dietary supplement.
Carbon-sulfur ligases are enzymes that catalyze the formation of carbon-sulfur bonds in organic molecules. These enzymes are important in the biosynthesis of various sulfur-containing compounds, such as cysteine and methionine, which are essential amino acids in proteins. Carbon-sulfur ligases are also involved in the metabolism of sulfur-containing compounds, such as hydrogen sulfide and mercaptans. In the medical field, carbon-sulfur ligases are of interest because they play a role in the development and progression of certain diseases, such as cancer and neurodegenerative disorders. Additionally, carbon-sulfur ligases are being studied as potential targets for the development of new drugs.
In the medical field, carrier proteins are proteins that transport molecules across cell membranes or within cells. These proteins bind to specific molecules, such as hormones, nutrients, or waste products, and facilitate their movement across the membrane or within the cell. Carrier proteins play a crucial role in maintaining the proper balance of molecules within cells and between cells. They are involved in a wide range of physiological processes, including nutrient absorption, hormone regulation, and waste elimination. There are several types of carrier proteins, including facilitated diffusion carriers, active transport carriers, and ion channels. Each type of carrier protein has a specific function and mechanism of action. Understanding the role of carrier proteins in the body is important for diagnosing and treating various medical conditions, such as genetic disorders, metabolic disorders, and neurological disorders.
In the medical field, an amino acid sequence refers to the linear order of amino acids in a protein molecule. Proteins are made up of chains of amino acids, and the specific sequence of these amino acids determines the protein's structure and function. The amino acid sequence is determined by the genetic code, which is a set of rules that specifies how the sequence of nucleotides in DNA is translated into the sequence of amino acids in a protein. Each amino acid is represented by a three-letter code, and the sequence of these codes is the amino acid sequence of the protein. The amino acid sequence is important because it determines the protein's three-dimensional structure, which in turn determines its function. Small changes in the amino acid sequence can have significant effects on the protein's structure and function, and this can lead to diseases or disorders. For example, mutations in the amino acid sequence of a protein involved in blood clotting can lead to bleeding disorders.
Acylation is a chemical reaction in which an acyl group (a group consisting of a carbonyl group and a hydrocarbon chain) is added to a molecule. In the medical field, acylation is often used to modify proteins or other biomolecules, such as lipids or carbohydrates, by attaching an acyl group to them. This can alter the function or stability of the molecule, and is sometimes used as a way to study or treat diseases. For example, acylation can be used to modify the structure of certain drugs, making them more effective or less toxic. It can also be used to study the role of specific acyl groups in cellular processes or signaling pathways.
Thiolester hydrolases are a class of enzymes that catalyze the hydrolysis of thioesters, which are esters containing a sulfur atom in place of an oxygen atom. These enzymes are important in a variety of biological processes, including the breakdown of fatty acids and the synthesis of certain amino acids. In the medical field, thiolester hydrolases are of interest because they are involved in the metabolism of lipids, which are essential components of cell membranes and a source of energy for the body. Abnormalities in the activity of thiolester hydrolases can lead to a variety of health problems, including obesity, diabetes, and cardiovascular disease. Thiolester hydrolases are also being studied as potential targets for the development of new drugs for the treatment of these conditions. For example, drugs that inhibit the activity of thiolester hydrolases may be effective in reducing the levels of harmful lipids in the blood and improving the health of individuals with metabolic disorders.
Malonyl Coenzyme A (Malonyl-CoA) is a molecule that plays a crucial role in fatty acid metabolism. It is synthesized from acetyl-CoA and malate, and is involved in the regulation of fatty acid synthesis and breakdown. Malonyl-CoA is also a key molecule in the process of gluconeogenesis, which is the production of glucose from non-carbohydrate sources. In the medical field, Malonyl-CoA is often studied in relation to metabolic disorders such as obesity, diabetes, and cardiovascular disease.
Cerulenin is a chemical compound that has been used in the medical field as an antibiotic. It is a blue-green pigment that is produced by certain bacteria, and it has been found to be effective against a variety of gram-negative bacteria, including Escherichia coli, Pseudomonas aeruginosa, and Salmonella typhimurium. Cerulenin works by inhibiting the production of fatty acids in bacteria, which are essential for the growth and survival of these organisms. This leads to the death of the bacteria, and can be used to treat bacterial infections in humans and animals. Cerulenin has also been studied for its potential use in treating other conditions, such as cancer and inflammatory diseases. However, more research is needed to fully understand its potential therapeutic applications.
Acyl Coenzyme A (acyl-CoA) is a molecule that plays a central role in metabolism. It is formed when an acyl group (a fatty acid or other long-chain hydrocarbon) is attached to the coenzyme A molecule, which is a small molecule that contains a thiol (-SH) group. Acyl-CoA molecules are involved in a variety of metabolic processes, including the breakdown of fatty acids (beta-oxidation), the synthesis of fatty acids (fatty acid synthesis), and the synthesis of other important molecules such as cholesterol and ketone bodies. In the medical field, acyl-CoA is often measured as a way to assess the activity of certain metabolic pathways, and imbalances in acyl-CoA levels can be associated with a variety of diseases and disorders.
Apoproteins are proteins that are associated with lipids (fats) in the bloodstream. They play a crucial role in the transport and metabolism of lipids in the body. There are several different types of apolipoproteins, each with a specific function. Apolipoproteins are found in lipoprotein particles, which are complexes of lipids and proteins that transport lipids through the bloodstream. The different types of apolipoproteins are associated with different types of lipoproteins, such as low-density lipoprotein (LDL) and high-density lipoprotein (HDL). Apolipoproteins are important for maintaining healthy lipid levels in the body. For example, HDL, which is often referred to as "good cholesterol," contains the apolipoprotein A-I, which helps to remove excess cholesterol from the bloodstream and transport it back to the liver for processing and elimination. Abnormal levels of apolipoproteins can be associated with various health conditions, such as high cholesterol, heart disease, and diabetes. Therefore, measuring levels of apolipoproteins can be an important part of diagnosing and managing these conditions.
Cloning, molecular, in the medical field refers to the process of creating identical copies of a specific DNA sequence or gene. This is achieved through a technique called polymerase chain reaction (PCR), which amplifies a specific DNA sequence to produce multiple copies of it. Molecular cloning is commonly used in medical research to study the function of specific genes, to create genetically modified organisms for therapeutic purposes, and to develop new drugs and treatments. It is also used in forensic science to identify individuals based on their DNA. In the context of human cloning, molecular cloning is used to create identical copies of a specific gene or DNA sequence from one individual and insert it into the genome of another individual. This technique has been used to create transgenic animals, but human cloning is currently illegal in many countries due to ethical concerns.
In the medical field, Nitrate Reductases are enzymes that catalyze the reduction of nitrate ions (NO3-) to nitrite ions (NO2-). These enzymes are found in a variety of organisms, including bacteria, plants, and animals. In the context of human health, Nitrate Reductases are of particular interest because they play a role in the production of nitric oxide (NO), a molecule that has a number of important physiological functions. Nitric oxide is a potent vasodilator, meaning that it helps to relax and widen blood vessels, which can improve blood flow and lower blood pressure. In addition to their role in nitric oxide production, Nitrate Reductases have also been implicated in a number of other physiological processes, including the regulation of gene expression, the detoxification of harmful substances, and the maintenance of the balance of oxygen and nitrogen in the body. Overall, Nitrate Reductases are an important class of enzymes that play a variety of roles in human health and physiology.
In the medical field, a multienzyme complex is a group of two or more enzymes that are physically and functionally linked together to form a single, larger enzyme complex. These complexes can work together to catalyze a series of sequential reactions, or they can work in parallel to carry out multiple reactions simultaneously. Multienzyme complexes are found in a variety of biological processes, including metabolism, DNA replication and repair, and signal transduction. They can be found in both prokaryotic and eukaryotic cells, and they can be composed of enzymes from different cellular compartments. One example of a multienzyme complex is the 2-oxoglutarate dehydrogenase complex, which is involved in the citric acid cycle and the metabolism of amino acids. This complex consists of three enzymes that work together to catalyze the conversion of 2-oxoglutarate to succinyl-CoA. Multienzyme complexes can have important implications for human health. For example, mutations in genes encoding enzymes in these complexes can lead to metabolic disorders, such as maple syrup urine disease and glutaric acidemia type II. Additionally, some drugs target specific enzymes in multienzyme complexes as a way to treat certain diseases, such as cancer.
Hydroxymethylglutaryl CoA reductases (HMG-CoA reductases) are a class of enzymes that play a critical role in the metabolism of lipids in the body. Specifically, they catalyze the conversion of hydroxymethylglutaryl-CoA (HMG-CoA) to mevalonate, which is a precursor for the synthesis of cholesterol and other isoprenoid compounds. There are two main types of HMG-CoA reductases: HMG-CoA reductase 1 and HMG-CoA reductase 2. HMG-CoA reductase 1 is primarily found in the liver and is responsible for most of the cholesterol synthesis in the body. HMG-CoA reductase 2 is found in other tissues, including the kidneys, adrenal glands, and the small intestine, and is responsible for a smaller amount of cholesterol synthesis. In the medical field, HMG-CoA reductases are important targets for the treatment of hyperlipidemia, a condition characterized by high levels of cholesterol and triglycerides in the blood. Statins, a class of drugs that inhibit HMG-CoA reductase activity, are commonly used to lower cholesterol levels and reduce the risk of cardiovascular disease.
Anthraquinones are a group of naturally occurring organic compounds that are derived from the anthracene molecule. They are commonly found in plants, particularly in the roots, bark, and leaves of certain species. Anthraquinones have a variety of biological activities, including anti-inflammatory, anti-cancer, and anti-microbial properties. In the medical field, anthraquinones are used as ingredients in a number of medications and natural remedies. For example, some anthraquinones are used as laxatives to relieve constipation, while others are used to treat inflammatory bowel disease. Anthraquinones have also been studied for their potential use in treating cancer, particularly in the treatment of colon cancer and other types of gastrointestinal cancer.
Coriandrum is a genus of plants in the family Apiaceae, commonly known as cilantro or coriander. In the medical field, coriander is used as a traditional medicine for various purposes, including: 1. Digestive disorders: Coriander is believed to have carminative properties, which means it can help relieve gas, bloating, and indigestion. 2. Antioxidant activity: Coriander contains antioxidants that can help protect the body against damage from free radicals. 3. Anti-inflammatory effects: Coriander has been shown to have anti-inflammatory properties, which may help reduce inflammation in the body. 4. Antimicrobial activity: Coriander has been found to have antimicrobial properties, which may help fight off infections caused by bacteria and fungi. 5. Hypoglycemic effects: Coriander has been shown to lower blood sugar levels, which may be beneficial for people with diabetes. However, it is important to note that while coriander has been used in traditional medicine for centuries, there is limited scientific evidence to support its effectiveness for these purposes. More research is needed to fully understand the potential health benefits of coriander.
In the medical field, a base sequence refers to the specific order of nucleotides (adenine, thymine, cytosine, and guanine) that make up the genetic material (DNA or RNA) of an organism. The base sequence determines the genetic information encoded within the DNA molecule and ultimately determines the traits and characteristics of an individual. The base sequence can be analyzed using various techniques, such as DNA sequencing, to identify genetic variations or mutations that may be associated with certain diseases or conditions.
3-oxoacyl-(acyl-carrier-protein) reductase (NADH)
List of EC numbers (EC 1)
Index of molecular biology articles
List of MeSH codes (D08)
List of EC numbers (EC 2)
3-oxoacyl-(acyl-carrier-protein) reductase - Wikipedia
ENZYME - 126.96.36.199 3-oxoacyl-[acyl-carrier-protein] reductase (NADH)
Crystal structure of a 3-oxoacyl-(acylcarrier protein) reductase (BA3989) from Bacillus anthracis at 2.4-A resolution. - Oxford...
BiGG Reaction 3OAR121 in iEcDH1 1363
RCSB PDB - 3TZC: Crystal structure of 3-ketoacyl-(acyl-carrier-protein) reductase (FabG)(Y155F) from Vibrio cholerae
Network Portal - Gene BC2557
May | 2020 | IKK signal
October | 2017 | CFTR Pathway
March | 2019 | Mdm Signaling
Metabolic Flux-Based Modularity using Shortest Retroactive distances | BMC Systems Biology | Full Text
DeCS 2017 - December 21, 2017 version
DeCS 2019 - June 12, 2019 version
DeCS 2020 - June 23, 2020 version
DeCS 2017 - December 21, 2017 version
DeCS 2017 - July 04, 2017 version
Mytilus trossulus Iso-seq Annotation - quarter-shell - The lab notebook of Steven Roberts
Carbon dioxide (YMDB00912) - Yeast Metabolome Database
DeCS 2014 - Novos termos
DeCS 2016 - July 28, 2016 version
DeCS 2015 - October 09, 2015 version
3-oxoacyl-[acyl-carrier-protein] synthase activity [GO 0004315] | Virtual Fly Brain
Zm00001e032495 P001 details
PRIME PubMed | Restoring enzyme activity in nonfunctional low erucic acid Brassica napus fatty acid elongase 1 by a single...
- β-Ketoacyl-(acyl carrier protein) reductase (FabG) catalyzes the key reductive reaction in the elongation cycle of fatty acid synthesis (FAS), which is a vital metabolic pathway in bacteria and a promising target for new antibiotic development. (rcsb.org)
- In the case of a metabolic reaction network, gene or even protein expression data may not best capture the interactions between the network's components, as mRNA levels or enzyme concentrations do not necessarily correlate with reaction rate or metabolite turnover. (biomedcentral.com)
- Cascade aza-Piancatelli reaction and [3+3]/[4+2] cycloaddition reactions are carried out using the ideality principles of pot, atom, and step economy (PASE) synthesis. (bvsalud.org)
- Here we report the findings of structural, enzymatic, and binding studies of the FabG protein found in the causative agent of cholera, Vibrio cholerae (vcFabG). (rcsb.org)
Enzyme that catalyzes1
- An NAD + dependent enzyme that catalyzes the oxidation of 3-carboxy-2-hydroxy-4-methylpentanoate to 3-carboxy-4-methyl-2-oxopentanoate. (nih.gov)
- The exact mechanism of cell death from GO remains uncertain although a slight increase in lactate dehydrogenase (LDH) from cells, generation of reactive oxygen species, and weak activation of a caspase-3-mediated apoptosis pathway have all been reported. (ikk-signal.com)
- Overall, while removing anomalies in the fundamental recognition mechanisms, the current study further substantiates how chiral fidelity is perpetuated during protein biosynthesis. (bvsalud.org)
- Crystal structure of a 3-oxoacyl-(acylcarrier protein) reductase (BA3989) from Bacillus anthracis at 2.4-A resolution. (ox.ac.uk)
- In agreement with published findings regarding different HEA and LEA B. napus cultivars, comparison of FAE1 protein sequences from HEA and LEA Brassicaceae revealed one crucial amino acid difference: the serine residue at position 282 of the HEA FAE1 sequences is substituted by phenylalanine in LEA B. napus cv. (unboundmedicine.com)
- Recently, Tang and coworkers used gene expression data to construct time-course protein interaction networks, and found that functional modules detected in the time-course networks more closely matched known regulatory complexes than those detected in the static networks[ 11 ]. (biomedcentral.com)
- Interestingly, mutations in hub proteins connecting different modules were found to be more frequently associated with cancer phenotypes than mutations in hub proteins that are highly connected with other proteins in the same modules, suggesting that alterations in global modularity may occur in cancer. (biomedcentral.com)
- A 3-oxoacyl reductase that has specificity for ACYL CARRIER PROTEIN-derived FATTY ACIDS . (nih.gov)
- 7/29/2013) TOTAL 2014 NEW DESCRIPTORS = 304 MH - 3-Hydroxyacyl-CoA Dehydrogenase UI - D063988 MN - D8.811.682.47.820.150.207 MS - An NAD-dependent 3-hydroxyacyl CoA dehydrogenase that has broad specificity with regards to the acyl chain length of the substrate. (nih.gov)
- use 3-HYDROXYACYL COA DEHYDROGENASES 1981-2013 MH - 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase UI - D064431 MN - D8.811.682.47.820.196 MS - A 3-oxoacyl reductase that has specificity for ACYL CARRIER PROTEIN-derived FATTY ACIDS. (nih.gov)
- carbonyl reductase 4 / 3-oxoacyl-[acyl-carrier protein] reductase beta subunit [EC:1.1.1. (kegg.jp)
- The Pseudomonas aeruginosa rhlG gene encodes an NADPH-dependent beta-ketoacyl reductase which is specifically involved in rhamnolipid synthesis. (nih.gov)
- A Pseudomonas aeruginosa gene homologous to the fabG gene, which encodes the NADPH-dependent beta-ketoacyl-acyl carrier protein (ACP) reductase required for fatty acid synthesis, was identified. (nih.gov)
- We conclude that the P. aeruginosa rhlG gene encodes an NADPH-dependent beta-ketoacyl reductase absolutely required for the synthesis of the beta-hydroxy acid moiety of rhamnolipids and that it has a minor role in PHA production. (nih.gov)
- The systematic name of this enzyme class is (3R)-3-hydroxyacyl-[acyl-carrier-protein]:NADP+ oxidoreductase. (wikipedia.org)
- These results suggest that the synthetic pathway for the fatty acid moiety of rhamnolipids is separate from the general fatty acid synthetic pathway, starting with a specific ketoacyl reduction step catalyzed by the RhlG protein. (nih.gov)
- In addition, the synthesis of poly-beta-hydroxyalkanoate (PHA) is delayed in this mutant, suggesting that RhlG participates in PHA synthesis, although it is not the only reductase involved in this pathway. (nih.gov)
- Hits to curated proteins without experimental data as to their function are never considered high confidence. (lbl.gov)
- HN - 2014 FX - Ammonia MH - Anaphase-Promoting Complex-Cyclosome UI - D064173 MN - D8.811.464.938.750.92 MN - D12.776.167.24 MS - An E3 ubiquitin ligase primarily involved in regulation of the metaphase-to-anaphase transition during MITOSIS through ubiquitination of specific CELL CYCLE PROTEINS. (nih.gov)
- Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam ). (lbl.gov)
- GapMind searches the predicted proteins for candidates by using ublast (a fast alternative to protein BLAST) to find similarities to characterized proteins or by using HMMer to find similarities to enzyme models (usually from TIGRFams ). (lbl.gov)